Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

NCT00241410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I Hypersensitivity

Interventions

BIOLOGICAL: OralvacB2MPL

Sponsor

Allergy Therapeutics